A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases.
Kastriot KastratiDaniel AletahaGerd-Rüdiger R BurmesterEva ChwalaChristian DejacoMaxime DougadosIain B McInnesAngelo RavelliNaveed SattarTanja Alexandra StammTsutomu TakeuchiMichael TraunerDésirée Mfm van der HeijdeMarieke J H VoshaarKevin L WinthropJosef S SmolenAndreas KerschbaumerPublished in: RMD open (2022)
IL-6 inhibition is effective for treatment of several inflammatory diseases with a safety profile that is widely comparable to other bDMARDs.